B 417 (Mephobarbital 50 mg)
Pill imprint B 417 has been identified as Mephobarbital 50 mg.
Mephobarbital is used in the treatment of sedation; seizure prevention; epilepsy and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Mephobarbital 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- B 417
- Strength:
- 50 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Barbiturate anticonvulsants
Barbiturates - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Breckenridge Pharmaceutical Inc
- National Drug Code (NDC):
- 51991-0417
More about mephobarbital
Consumer resources
- Other brands: Mebaral
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
